Actively Recruiting
UAE-PRIME Study of a Robotically Implanted Brain-Computer Interface Device for People with Severe Arm Weakness
Led by Neuralink Corp · Updated on 2025-06-05
10
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and function of the Neuralink N1 Implant and the R1 Robot in people who have tetraparesis, tetraplegia, or conditions that may lead to these disabilities. This feasibility study focuses on a wireless brain-computer interface device implanted in the brain using a precise robotic system. The goal is to understand how well the device and procedure work and how safe they are for participants with severe upper limb motor impairments. The study uses the N1 Implant, a rechargeable device placed on the skull, connected to thin electrode threads inserted into the brain by the R1 Robot. This robotic device is specially designed for the implantation procedure. The trial is open label, meaning all participants receive the implant, and the study will monitor them over time to assess outcomes related to the device and procedure. Participants will be followed for up to 36 months after implantation. Researchers will regularly assess safety by tracking device- and procedure-related adverse events at 12 months and up to 36 months post-implant. They will also measure changes in cognitive function, mood, anxiety, and neurological status using standardized questionnaires and exams at multiple time points. Participants need to communicate verbally or via a computer, and a caregiver must be present to support them throughout the study.
CONDITIONS
Brief Title
UAE-PRIME: A Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices
Research Team
N
Neuralink Clinical Team
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here